| Facilitation of drug evaluation in children by population methods and modelling M Tod, V Jullien, G Pons Clinical pharmacokinetics 47, 231-243, 2008 | 210 | 2008 |
| Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients B Blanchet, V Jullien, C Vinsonneau, M Tod Clinical pharmacokinetics 47, 635-654, 2008 | 176 | 2008 |
| A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy B Ribba, G Kaloshi, M Peyre, D Ricard, V Calvez, M Tod, ... Clinical Cancer Research 18 (18), 5071-5080, 2012 | 174 | 2012 |
| Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice B Blanchet, B Billemont, J Cramard, AS Benichou, S Chhun, L Harcouet, ... Journal of pharmaceutical and biomedical analysis 49 (4), 1109-1114, 2009 | 150 | 2009 |
| Pharmacokinetic–pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema F Audren, M Tod, P Massin, R Benosman, B Haouchine, A Erginay, ... Investigative ophthalmology & visual science 45 (10), 3435-3441, 2004 | 140 | 2004 |
| Aminoglycosides O Lortholary, M Tod, O Petitjean, Y Cohen Medical Clinics of North America 79 (4), 761-787, 1995 | 140 | 1995 |
| Azithromycin for COVID-19: more than just an antimicrobial? N Bleyzac, S Goutelle, L Bourguignon, M Tod Clinical drug investigation 40, 683-686, 2020 | 137 | 2020 |
| Clinical pharmacokinetics of diacerein P Nicolas, M Tod, C Padoin, O Petitjean Clinical pharmacokinetics 35, 347-359, 1998 | 131 | 1998 |
| Microbiologic epidemiology depending on time to occurrence of prosthetic joint infection: a prospective cohort study C Triffault-Fillit, T Ferry, F Laurent, P Pradat, C Dupieux, A Conrad, ... Clinical Microbiology and Infection 25 (3), 353-358, 2019 | 120 | 2019 |
| Salvage debridement, antibiotics and implant retention (“DAIR”) with local injection of a selected cocktail of bacteriophages: is it an option for an elderly patient with … T Ferry, G Leboucher, C Fevre, Y Herry, A Conrad, J Josse, C Batailler, ... Open forum infectious diseases 5 (11), ofy269, 2018 | 117 | 2018 |
| Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary study P Boudou-Rouquette, C Narjoz, JL Golmard, A Thomas-Schoemann, ... Public Library of Science 7 (8), e42875, 2012 | 114 | 2012 |
| Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysis P Boudou-Rouquette, S Ropert, O Mir, R Coriat, B Billemont, M Tod, ... The oncologist 17 (9), 1204-1212, 2012 | 111 | 2012 |
| Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders. G Andreu, A Leon, F Heshmati, M Tod, CJ Menkes, J Baudelot, L Laroche Transfusion science 15 (4), 443-454, 1994 | 104 | 1994 |
| Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia O Lortholary, A Lefort, M Tod, AM Chomat, C Darras-Joly, C Cordonnier The Lancet infectious diseases 8 (10), 612-620, 2008 | 103 | 2008 |
| Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysis M Tod, F Lokiec, R Bidault, F De Bony, O Petitjean, Y Aujard, ... Antimicrobial agents and chemotherapy 45 (1), 150-157, 2001 | 96 | 2001 |
| Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of … T Ferry, F Boucher, C Fevre, T Perpoint, J Chateau, C Petitjean, J Josse, ... Journal of Antimicrobial Chemotherapy 73 (10), 2901-2903, 2018 | 90 | 2018 |
| Population pharmacokinetic study of teicoplanin in severely neutropenic patients O Lortholary, M Tod, N Rizzo, C Padoin, O Biard, P Casassus, L Guillevin, ... Antimicrobial agents and chemotherapy 40 (5), 1242-1247, 1996 | 88 | 1996 |
| Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients O Mimoz, V Binter, A Jacolot, A Edouard, M Tod, O Petitjean, K Samii Intensive care medicine 24, 1047-1051, 1998 | 80 | 1998 |
| Understanding polyspecificity within the substrate‐binding cavity of the human multidrug resistance P‐glycoprotein L Martinez, O Arnaud, E Henin, H Tao, V Chaptal, R Doshi, T Andrieu, ... The FEBS journal 281 (3), 673-682, 2014 | 79 | 2014 |
| A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers B Ribba, E Watkin, M Tod, P Girard, E Grenier, B You, E Giraudo, G Freyer European Journal of Cancer 47 (3), 479-490, 2011 | 74 | 2011 |
